Susan Domchek, MD is a medical oncologist and the Director of the Basser Center at the Perelman School of Medicine. She is a nationally recognized expert in the translation of genetic testing for cancer susceptibility into clinical care of patients in the areas of prevention, early detection, and cancer treatment. Dr. Domchek’s research interests include implementing novel strategies to improve uptake of genetic testing, further understanding specific risks associated with cancer susceptibility genes, and developing more effective therapies for BRCA1/2 mutation associated cancers. Dr. Domchek is a member of the National Academy of Medicine.
She holds an MD from Harvard University, and completed her residency at Massachusetts General Hospital, and her fellowship at Dana-Farber Cancer Institute.